Today: 23 April 2026
Subscribe
Browse Category

Stock Market 9 December 2025

Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce shares traded near $260 on December 9, 2025, after reporting record Q3 results and raising its full-year outlook. The company posted Q3 revenue of about $10.3 billion, up 9% year-over-year, and adjusted EPS of $3.25, beating estimates. Market cap stood at roughly $243 billion. The stock remains about 25–30% lower for 2025 despite the recent rebound.
9 December 2025
···
Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma shares fell 4.2% to around $197.25 in late trading December 9 after a Q3 earnings miss and a three-month FDA review delay for its key dwarfism drug. Volume was about 76% below average. The company posted Q3 revenue of €213.6 million but reported a net loss of €61 million, mainly from finance expenses. Despite the pullback, ASND remains near its 52-week high and up year-on-year.
9 December 2025
··
BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies shares jumped 8.4% to $38.85 intraday on December 9, 2025, after confirming control of 3.86 million ETH—over 3.2% of all Ethereum—and a $13.2 billion crypto and cash reserve. The company’s market cap stands at $14.8 billion with a trailing P/E of about 2.7. The stock traded between $34.66 and $39.25 during the session. Volume averaged 45 million shares over 30 days.
9 December 2025
····
KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (NYSE: BEKE) shares fell about 4.8% Tuesday, opening near $16.35 after closing at $17.08, with over 1 million shares traded. The drop came despite ongoing share buybacks and Q3 revenue rising 2.1% year-on-year to RMB 23.1 billion. Net income fell to RMB 747 million from RMB 1.17 billion a year earlier. BEKE underperformed even as international ETF VXUS saw strong inflows.
9 December 2025
····
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics shares traded at $17–18 on December 9, 2025, near the low end of their 52-week range of $15.55 to $36.91. The company’s lung cancer drug ivonescimab recently outperformed Keytruda in a limited trial, drawing attention but also regulatory questions. Summit granted inducement stock options to new hires on December 5. The company’s market cap stands near $13–14 billion.
9 December 2025
·
Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group shares traded near $169 on December 9, 2025, down from a record $213.80 hit a week earlier after strong earnings. The company reported Q2 fiscal 2026 revenue of $268 million, far above estimates, and net income of $82.6 million versus a loss last year. Management raised Q3 guidance to $335–$345 million in revenue, citing demand from AI data centers.
9 December 2025
···
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals shares traded at $26–27 on December 9, up over 800% from their 52-week low but 12% below the recent high. The stock surged after Roche’s positive Phase 3 results for a similar breast cancer drug, triggering analyst upgrades and price target hikes. Market capitalization now stands near $2–2.2 billion. Analyst 12-month targets range from $20 to $55, with most rating the stock a strong buy.
9 December 2025
··
Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises reported Q1 net sales of $8.17–8.2 billion, up 5.1% year-on-year, and adjusted diluted EPS of $2.84, up 15.9%. Shares fell sharply despite raised full-year guidance, as investors weighed valuations and growth forecasts. Residential revenue slipped 1%, while non-residential revenue jumped 12% on strong commercial demand. The company now targets 5% net sales growth for 2025.
9 December 2025
···
Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging shares fell to a new 52-week low near $14 on December 9, 2025, after the company cut its full-year earnings outlook and announced cost and production optimization measures. Trading volume topped 10 million shares. The company also confirmed a CEO transition for early 2026. Net sales guidance remains at $8.4–$8.6 billion.
9 December 2025
··
Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems shares traded at $141.72 on December 9, 2025, after a volatile year that included a 21% surge two weeks prior following an analyst upgrade and positive reimbursement news. Q3 revenue rose 10% to $224.5 million, with net income at $9.9 million and adjusted EPS of $0.38, beating estimates. The company also launched its new Inspire 5 system.
9 December 2025
·
Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands shares traded between $75 and $76 on December 9, about 19% below their January high, after falling 3–4% intraday amid weak consumer data. Wells Fargo raised its price target to $100 and reiterated an “overweight” rating. Marshall Wace trimmed its stake following recent gains. Kontoor’s Q3 revenue rose 27% to $853 million, with EPS of $1.44 beating forecasts.
9 December 2025
··
AutoZone (AZO) Stock Plunges After Q1 2026 Earnings Miss — What Investors Need to Know Today

AutoZone (AZO) Stock Plunges After Q1 2026 Earnings Miss — What Investors Need to Know Today

AutoZone shares fell about 7–8% Tuesday after fiscal Q1 2026 results missed profit estimates, making it the S&P 500’s worst performer. Net sales rose 8.2% to $4.63 billion, but net income dropped to $530.8 million from $564.9 million a year earlier. Diluted EPS came in at $31.04, below analyst forecasts and marking a sixth straight quarterly miss. Trading volume surged as investors reacted to weaker margins and guidance.
9 December 2025
··
Stock Market Today: Wall Street Rises as Fed Cut Looms, Nvidia Gets China Nod

Stock Market Today: Wall Street Rises as Fed Cut Looms, Nvidia Gets China Nod

U.S. stocks rose slightly on December 9, 2025, as the Federal Reserve began a meeting expected to produce a quarter-point rate cut. Nvidia shares moved after President Trump approved conditional H200 AI chip exports to China. The Dow gained 0.1%–0.3%, while the S&P 500 and Nasdaq were up about 0.2%. A bidding war for Warner Bros. added volatility.
9 December 2025
····
D-Wave Quantum (QBTS) Stock in December 2025: Rally, Volatility, and What Analysts Expect Next

D-Wave Quantum (QBTS) Stock in December 2025: Rally, Volatility, and What Analysts Expect Next

D-Wave Quantum shares traded at $27–28 on December 9, 2025, up over 200% year to date after sharp swings. The stock plunged nearly 40% in November before rebounding more than 20% in early December, driven by bullish analyst coverage and renewed investor interest. Evercore ISI initiated coverage with an “Outperform” rating and a $44 target. Institutional investors have increased positions as volatility remains high.
9 December 2025
···
Hawaiian Electric Industries (HE) Stock Soars on S&P 600 Inclusion – Latest News, Maui Settlement Update and 2026 Forecasts

Hawaiian Electric Industries (HE) Stock Soars on S&P 600 Inclusion – Latest News, Maui Settlement Update and 2026 Forecasts

Hawaiian Electric Industries stock surged over 11% on December 8, 2025, after S&P Dow Jones Indices announced its addition to the S&P SmallCap 600. Shares traded near $11.73 on December 9, with market cap at $2.1 billion. The move follows a year of legal pressure from Maui wildfire settlements, with analysts maintaining a “Hold” rating. Trading volume spiked to 1.4 million shares, well above normal levels.
9 December 2025
··
1 … 1,029 1,030 1,031 1,032 1,033 … 1,384

Stock Market Today

  • iShares S&P 500 Growth ETF IVW Sees $225.9 Million Inflows; NFLX, ISRG, WELL Among Key Holdings
    April 23, 2026, 12:18 PM EDT. The iShares S&P 500 Growth ETF (IVW) recorded a $225.9 million inflow, marking a 0.3% increase in outstanding units week-over-week. Notable underlying stocks include Netflix Inc (NFLX), up 0.4%, Intuitive Surgical Inc (ISRG), unchanged, and Welltower Inc (WELL), rising 1.9%. IVW's share price trades near its 52-week high, suggesting strong investor interest. ETF inflows imply increased buying of the ETF's components as new units are created to meet demand. The 200-day moving average remains a key technical benchmark in assessing IVW's price trend. Regular monitoring of ETF unit changes offers insight into market flows affecting both ETFs and their constituent stocks.

Latest article

Texas Instruments (TXN) Stock Jumps After Earnings Beat as Q2 Forecast Tops Wall Street

Texas Instruments (TXN) Stock Jumps After Earnings Beat as Q2 Forecast Tops Wall Street

23 April 2026
Texas Instruments forecast second-quarter revenue of $5.0–$5.4 billion and earnings of $1.77–$2.05 a share, topping Wall Street estimates. First-quarter revenue rose 19% to $4.83 billion, with industrial sales up over 30% and data-center revenue up 90% from a year earlier. Shares jumped about 16% early Thursday. The company received $555 million from the U.S. CHIPS Act.
GameStop Stock Today: GME Slips as $420 Trade-In Buzz Fades and Valuation Debate Returns

GameStop Stock Today: GME Slips as $420 Trade-In Buzz Fades and Valuation Debate Returns

23 April 2026
GameStop shares fell 1.6% to $25.24 Thursday morning, reversing part of Wednesday’s rally after a limited trade-in promotion ended. The company’s offer gave Pro members up to $420.69 for console trade-ins through April 22, but values returned to normal by Thursday. GameStop reported a 14% drop in fourth-quarter revenue in March and is shifting focus to trading cards and collectibles.
IBM Earnings Beat Isn’t Enough as AI Fears Slam Software Stocks

IBM Earnings Beat Isn’t Enough as AI Fears Slam Software Stocks

23 April 2026
IBM shares dropped 9.5% Thursday despite first-quarter earnings beating estimates, as investors worried AI tools could threaten its software and consulting business. ServiceNow fell 17.5% and the iShares Expanded Tech-Software ETF lost 5.6%. IBM reported $15.9 billion in revenue, up 9%, but growth slowed from the prior quarter and guidance was unchanged.
Go toTop